Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma
Research output: Contribution to journal › Article
- Translational Laboratory Team, University of Birmingham, Birmingham, United Kingdom.
- Department of Oral and Maxillofacial Surgery, Queen Elizabeth Hospital
- Department of Head and Neck Surgery, Queen Elizabeth Hospital
- Department of Clinical Oncology, Queen Elizabeth Hospital
The use of circulating biochemical molecular markers in head and neck cancer holds the promise of improved diagnostics, treatment planning, and posttreatment surveillance. In this review, we provide an introduction for the head and neck surgeon of the basic science, current evidence, and future applications of circulating tumor DNA (ctDNA) as a biomarker and liquid biopsy to detect tumor genetic heterogeneity in patients with head and neck squamous cell carcinoma (HNSCC).
|Number of pages||7|
|Journal||Head & Neck|
|Early online date||15 Mar 2018|
|Publication status||Published - 1 Jul 2018|
- Journal Article, biomarker , circulating tumor DNA (ctDNA), head and neck cancer , liquid biopsy